Cara Therapeutics Inc banner

Cara Therapeutics Inc
NASDAQ:TVRD

Watchlist Manager
Cara Therapeutics Inc Logo
Cara Therapeutics Inc
NASDAQ:TVRD
Watchlist
Price: 3.76 USD -1.57% Market Closed
Market Cap: $35.3m

Cash Flow Statement

Cash Flow Statement
Cara Therapeutics Inc

Rotate your device to view
Cash Flow Statement
Currency: USD
Dec-2014 Mar-2015 Jun-2015 Sep-2015 Dec-2015 Mar-2016 Jun-2016 Sep-2016 Dec-2016 Mar-2017 Jun-2017 Sep-2017 Dec-2017 Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023 Mar-2024 Jun-2024 Sep-2024 Dec-2024
Operating Cash Flow
Net Income
(18)
(19)
(21)
(19)
(25)
(31)
(38)
(45)
(57)
(69)
(65)
(66)
(58)
(53)
(61)
(68)
(74)
(79)
(85)
(98)
(106)
(113)
(115)
(99)
8
14
8
24
(88)
(93)
(66)
(89)
(85)
(84)
(112)
(117)
(119)
(123)
(111)
(96)
(71)
Depreciation & Amortization
1
1
1
1
1
1
2
2
1
1
0
0
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Stock-Based Compensation
1
1
2
2
3
3
3
3
3
3
4
5
6
7
7
8
9
10
12
13
13
13
14
14
15
16
15
16
21
22
24
23
18
15
14
0
0
0
0
0
0
Other Non-Cash Items
(1)
(1)
(2)
(0)
1
1
2
2
2
3
4
5
6
6
60
54
50
46
(10)
(5)
(4)
(7)
(5)
(12)
(7)
3
7
17
23
25
26
25
19
17
15
15
17
20
22
27
27
Cash Interest Paid
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Change in Working Capital
0
(0)
2
(4)
2
2
1
3
6
6
1
4
(3)
(6)
2
4
1
1
(3)
1
1
(0)
(2)
(8)
(7)
(8)
1
(18)
5
6
(5)
7
(13)
(20)
(8)
3
9
14
9
(6)
(17)
Cash from Operating Activities
(18)
N/A
(20)
-12%
(20)
0%
(23)
-17%
(21)
+7%
(26)
-21%
(33)
-28%
(38)
-15%
(47)
-24%
(59)
-25%
(60)
-1%
(57)
+5%
(55)
+3%
(52)
+6%
1
N/A
(9)
N/A
(22)
-138%
(31)
-41%
(97)
-210%
(102)
-5%
(109)
-7%
(120)
-10%
(123)
-2%
(119)
+3%
(5)
+95%
9
N/A
16
+73%
23
+48%
(60)
N/A
(62)
-3%
(45)
+27%
(56)
-24%
(79)
-39%
(88)
-12%
(104)
-18%
(98)
+5%
(92)
+6%
(88)
+5%
(80)
+9%
(74)
+7%
(61)
+18%
Investing Cash Flow
Capital Expenditures
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(1)
(1)
(1)
(1)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
(0)
0
(0)
(0)
0
0
0
(0)
(0)
(0)
(0)
(0)
0
0
(0)
(2)
(3)
(3)
(3)
(1)
Other Items
0
0
0
0
(92)
(89)
(82)
(67)
46
58
(21)
(24)
(36)
(30)
(10)
(17)
(83)
(77)
(1)
(103)
(31)
(20)
22
159
(20)
(43)
(90)
(115)
(5)
15
24
31
129
113
116
118
46
55
38
17
50
Cash from Investing Activities
(0)
N/A
(0)
-25%
(0)
+20%
(0)
+50%
(92)
-458 300%
(89)
+3%
(82)
+8%
(67)
+18%
45
N/A
57
+27%
(21)
N/A
(24)
-13%
(37)
-52%
(31)
+16%
(10)
+66%
(17)
-65%
(83)
-391%
(77)
+7%
(1)
+99%
(103)
-13 644%
(31)
+70%
(20)
+35%
22
N/A
159
+615%
(20)
N/A
(43)
-114%
(90)
-108%
(115)
-28%
(5)
+96%
15
N/A
24
+62%
31
+28%
129
+319%
113
-12%
116
+3%
118
+2%
43
-63%
52
+19%
34
-34%
14
-60%
49
+260%
Financing Cash Flow
Net Issuance of Common Stock
58
0
0
76
76
76
76
(0)
0
0
88
88
88
88
17
110
111
111
99
143
143
142
139
1
39
40
40
40
47
46
46
46
0
1
1
2
2
0
0
0
0
Net Issuance of Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Other
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
36
36
35
34
(4)
Cash from Financing Activities
58
N/A
0
-100%
0
+4%
76
+31 521%
76
0%
76
+0%
76
0%
(0)
N/A
0
N/A
0
+92%
88
+38 017%
88
+0%
88
+0%
88
+0%
17
-81%
110
+564%
111
+0%
111
0%
99
-11%
143
+45%
143
0%
142
0%
139
-3%
1
-100%
39
+5 572%
40
+2%
40
+0%
40
0%
47
+17%
46
-1%
46
0%
46
-1%
0
-99%
1
+181%
1
-22%
2
+150%
38
+2 144%
37
-3%
36
-2%
34
-5%
(4)
N/A
Change in Cash
Net Change in Cash
40
N/A
(20)
N/A
(20)
N/A
53
N/A
(38)
N/A
(40)
-5%
(40)
0%
(106)
-167%
(2)
+98%
(2)
+17%
7
N/A
7
+7%
(3)
N/A
6
N/A
8
+31%
84
+998%
6
-93%
2
-59%
1
-70%
(62)
N/A
3
N/A
2
-13%
38
+1 430%
41
+6%
13
-67%
5
-59%
(35)
N/A
(52)
-51%
(18)
+65%
(1)
+94%
24
N/A
20
-19%
50
+154%
26
-48%
13
-50%
22
+66%
(10)
N/A
1
N/A
(9)
N/A
(26)
-178%
(16)
+40%
Free Cash Flow
Free Cash Flow
(18)
N/A
(20)
-12%
(20)
0%
(23)
-17%
(22)
+7%
(26)
-21%
(33)
-28%
(39)
-17%
(48)
-23%
(60)
-25%
(60)
-1%
(57)
+6%
(55)
+3%
(52)
+6%
1
N/A
(9)
N/A
(22)
-138%
(31)
-41%
(97)
-210%
(102)
-5%
(109)
-7%
(120)
-10%
(123)
-2%
(119)
+3%
(6)
+95%
9
N/A
16
+73%
23
+48%
(60)
N/A
(62)
-3%
(45)
+27%
(57)
-24%
(79)
-39%
(88)
-11%
(104)
-18%
(99)
+5%
(94)
+4%
(91)
+4%
(83)
+9%
(77)
+7%
(62)
+20%